Ixchel To 9th Circ. In Biogen Row: Companies Are People, Too

By Hannah Albarazi (May 15, 2019, 9:45 PM EDT) -- Ixchel Pharma LLC urged the Ninth Circuit at a hearing Wednesday to revive allegations that Biogen Inc. illegally undermined its development of a neuromuscular disease treatment by signing an anti-competitive deal with another company, arguing that California's legal restrictions on noncompetes should protect corporations, not just individual people....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!